Biotechnology company Humacyte, Inc. announces exclusive distribution rights for the innovative medical device Symvess outside the United States.

老虎证券2026/04/24 12:13

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

According to the terms of the agreement, medical giant Fresenius will receive a low single-digit percentage royalty from the net sales of this product. This collaboration will strengthen Humacyte's commercial presence in the global vascular repair sector, while also providing Fresenius with a continuous revenue stream.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Biotechnology company Humacyte, Inc. announces exclusive distribution rights for the innovative medical device Symvess outside the United States.

You may also like

Crypto prices